PharmaSGP to acquire four OTC brands from GSK

17 June 2021 - Deborah Wilkes

German consumer healthcare company PharmaSGP is acquiring a portfolio of four OTC brands in eight countries from GlaxoSmithKline (GSK) for around EUR80 million (USD95.5 million).